Skip to the page

Data / Drug companies / Ascend Laboratories, LLC

Ascend Laboratories, LLC: 357 products in the FDA NDC directory, labeler code 67877

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Ascend Laboratories, LLC (labeler code 67877) lists 357 products in the FDA National Drug Code Directory, covering 121 finished drugs by generic name. By type: 354 prescription drugs, 3 drugs for further processing. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 15, 2026.

The request: Watch Ascend Laboratories, LLC (FDA labeler code 67877): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
67877
Products in commercial distribution
357
Packages
1,089
Finished drugs by generic name
121
Prescription products
354
Over the counter products
0
Controlled substance products
Schedule II 12, Schedule III 5, Schedule IV 9, Schedule V 15
Flagged as original packager
304 of 304 products that carry the flag
Started marketing in the last 12 months
34
Earliest marketing start
December 23, 1985
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)35098%
Authorized generics (NDA)30.8%
Drugs for further processing30.8%
New drug applications (NDA)10.3%

Products by type

TypeProductsShare
Prescription drugs35499.2%
Drugs for further processing30.8%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Tolvaptan139
Pregabalin954
Metformin hydrochloride979
Cephalexin836
Minocycline hydrochloride829
Topiramate856
Quetiapine730
Deferasirox621
Amlodipine besylate649
Aripiprazole649
Temozolomide612
Olanzapine649
Ibuprofen6190
Gabapentin591
Lurasidone hydrochloride528
Methylphenidate hydrochloride539
Sacubitril and valsartan529
Hydralazine hydrochloride447
Valsartan438
Azathioprine419
Cefpodoxime proxetil411
Eslicarbazepine acetate410
Dapagliflozin and metformin hydrochloride410
Clobazam418
Levetiracetam487
Famotidine4138
Lamotrigine451
Mycophenolic acid416
Everolimus415
Rosuvastatin calcium434
Ezetimibe and simvastatin48
Venlafaxine433
Lacosamide457
Temazepam428
Nebivolol421
Atorvastatin calcium459
Amlodipine and olmesartan medoxomil410
Metoprolol succinate er tablets48
Triamcinolone acetonide377
Olmesartan medoxomil and hydrochlorothiazide317
Varenicline tartrate323
Sirolimus322
Cinacalcet318
Cefdinir325
Metformin hcl313
Tizanidne hydrochloride36
Deferasirox oral31
Droxidopa315
Dronabinol37
Duloxetine336
Dimethyl fumarate320
Dexmethylphenidate hydrochloride317
Mycophenolate mofetil337
Olmesartan medoxomil331
Dabigatran etexilate317
Lanthanum carbonate37
Tacrolimus335
Nifedipine338
Carbamazepine352
Telmisartan329
Cefprozil27
Roflumilast217
Ticagrelor232
Solifenacin succinate222
Methadone hydrochloride221
Rasagiline211
Finasteride231
Esomeprazole magnesium277
Ranolazine230
Dapagliflozin226
Tizanidine238
Imatinib mesylate217
Morphine sulfate231
Erythromycin236
Rizatriptan benzoate225
Esomeprazole magnesium delayed release capsules24
Buprenorphine and naloxone222
Febuxostat222
Fesoterodine fumarate212
Capecitabine219
Benzonatate242
Vancomycin hydrochloride239
Lansoprazole258
Chlorthalidone242
Cefuroxime axetil217
Oxcarbazepine146
Lacosamide oral solution11
Diclofenac potassium142
Itraconazole114
Cefixime17
Colchicine134
Riluzole17
Colesevelam hydrochloride112
Sodium sulfate, potassium sulfate and magnesium sulfate13
Chlordiazepoxide hydrochloride and clidinium bromide113
Linezolid128
Azelastine14
Ibuprofen and famotidine114
Mesalamine141
Choleystyramine light12

Dosage forms

Dosage formProductsShare
Tablet9827.5%
Tablet, film coated9626.9%
Capsule4713.2%
Tablet, film coated, extended release195.3%
Tablet, extended release154.2%
Solution102.8%
Capsule, delayed release92.5%
Kit92.5%
Powder, for suspension82.2%
Capsule, coated pellets61.7%
Tablet, delayed release51.4%
Capsule, extended release51.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Topiramate67877-796Capsule, extended releaseGeneric drugs (ANDA)October 15, 2026
Topiramate67877-795Capsule, extended releaseGeneric drugs (ANDA)October 15, 2026
Topiramate67877-794Capsule, extended releaseGeneric drugs (ANDA)October 15, 2026
Topiramate67877-793Capsule, extended releaseGeneric drugs (ANDA)October 15, 2026
Lidocaine67877-767PatchGeneric drugs (ANDA)September 22, 2026
Ibuprofen67877-739Tablet, film coatedGeneric drugs (ANDA)September 15, 2026
Ibuprofen67877-738Tablet, film coatedGeneric drugs (ANDA)September 15, 2026
Ibuprofen67877-737Tablet, film coatedGeneric drugs (ANDA)September 15, 2026
Tolvaptan67877-924KitGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-923KitGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-922KitGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-921KitGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-920KitGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-919TabletGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-918TabletGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-917TabletGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-916TabletGeneric drugs (ANDA)September 1, 2026
Tolvaptan67877-915TabletGeneric drugs (ANDA)September 1, 2026
Buprenorphine and naloxone67877-607TabletGeneric drugs (ANDA)July 3, 2026
Buprenorphine and naloxone67877-606TabletGeneric drugs (ANDA)July 3, 2026
Mirabegron67877-890For suspension, extended releaseGeneric drugs (ANDA)June 15, 2026
Mycophenolic acid67877-929Tablet, delayed releaseGeneric drugs (ANDA)April 21, 2026
Mycophenolic acid67877-928Tablet, delayed releaseGeneric drugs (ANDA)April 21, 2026
Dapagliflozin and metformin hydrochloride67877-622Tablet, film coated, extended releaseGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and metformin hydrochloride67877-621Tablet, film coated, extended releaseGeneric drugs (ANDA)April 6, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.